Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urination Disorders 1Urinary Bladder, Overactive 1

Interventions

Saline Solution 6Letrozole 6Fentanyl 6Sodium Chloride 5Dexamethasone 5Pregabalin 4Ketamine 4Goserelin 4Gemcitabine 4Bevacizumab 4Tranexamic Acid 3Photochemotherapy 3Pemetrexed 3Paclitaxel 3Metformin 3Leuprolide 3Docetaxel 3Cyclophosphamide 3Carboplatin 3Capecitabine 3Acetaminophen 3ulipristal acetate 2sodium glycididazole 2nilotinib 2liposomal doxorubicin 2human papillomavirus vaccine, L1 type 16, 18 2flurbiprofen axetil 2fludarabine 2fluciclovine F-18 2epoetin beta 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Terminated × Solifenacin Succinate × Clear all
NCT01777217 2015-01-16

VESIcare For Improving OAB Symptoms in Patients Undergoing IGRT of the Prostate

Advanced Research Network

Phase 4 Terminated
8 enrolled 6 charts
Genitourinary

Urination Disorders, Urinary Bladder, Overactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡